Inhibition of CDC20 Potentiates Anti-tumor Immunity Through Facilitating GSDME-Mediated Pyroptosis in Prostate Cancer

Researchers highlighted novel molecular pathways for targeting cellular pyroptosis and enhancing the effectiveness of anti-PD1-based immunotherapy. Prostate cancer cell lines were evaluated via the next-generation RNA sequencing to assess transcriptomic profile upon CDC20 depletion.